Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709621014 | Dinoprostone-containing product in vaginal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3709622019 | Product containing dinoprostone in vaginal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4653551000052110 | läkemedel som innehåller dinoproston, vaginal läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dinoprostone-containing product in vaginal dose form | Is a | Product containing dinoprostone (medicinal product) | true | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Has active ingredient | Dinoprostone (substance) | true | Inferred relationship | Some | 1 | |
| Dinoprostone-containing product in vaginal dose form | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Has active ingredient | Alprostadil | false | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Is a | Product manufactured as vaginal dose form (product) | true | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Has manufactured dose form | Vaginal dose form (dose form) | true | Inferred relationship | Some | ||
| Dinoprostone-containing product in vaginal dose form | Plays role | Oxytocic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| dinoproston 10 mg, vaginalinlägg | Is a | False | Dinoprostone-containing product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone 400 microgram/mL vaginal gel | Is a | False | Dinoprostone-containing product in vaginal dose form | Inferred relationship | Some | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Is a | False | Dinoprostone-containing product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone 3 mg vaginal tablet | Is a | False | Dinoprostone-containing product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone only product in vaginal dose form | Is a | True | Dinoprostone-containing product in vaginal dose form | Inferred relationship | Some |
Reference Sets
FHIR